BioHealth News
George Mason is part of Northern Virginia’s first innovation district, launched with transformational grant from GO Virginia
Thanks to a major investment from GO Virginia, Northern Virginia’s first Innovation District is taking shape, laying the groundwork for growth in high-tech industry…
Read More
Pediatrix Appoints Former Children’s National CEO and Former BHI Board Member Dr. Kurt Newman to Board of Directors
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced that its board of directors has appointed…
Read More
Navigating FDA Disruption: Insights from BHI EIR Kwame Ulmer
In a new video feature, BioHealth Innovation’s Entrepreneur-in-Residence (EIR) Kwame Ulmer offers a candid and experienced take on the evolving FDA landscape and its…
Read More
UVA Health: Additional $50 million raised for Manning Institute of Biotechnology
UVA Health has received two anonymous $25 million estate gifts to support the University of Virginia’s Paul and Diane Manning Institute of Biotechnology. The $50…
Read More
Aurinia Reports Strong Early Results for New Autoimmune Drug AUR200
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced positive results from a Phase 1 single-ascending-dose (SAD) study of aritinercept (AUR200),…
Read More
Apply Now for the BioHealth Capital Region Crab Trap Competition
Applications are now open for the 9th Annual Crab Trap Competition, one of the signature events of BioHealth Capital Region Week 2025, taking place…
Read More
I-Mab Reports Promising Givastomig Phase 1b Results in First-Line Gastric Cancer
ROCKVILLE, Md., June 26, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision…
Read More
Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH
GAITHERSBURG, Md., June 26, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic…
Read More
Emergent Secures $62.4M Contract Boost for Botulism Antitoxin to Support U.S. Biodefense
GAITHERSBURG, Md., June 23, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a $62.4 million contract modification from the Administration for Strategic…
Read More
BHI and the BioHealth Capital Region Partners Showcase Our Great Assets at BIO 2025 in Boston
The 2025 BIO International Convention brought together over 20,000 life sciences leaders from across the globe. BioHealth Innovation, Inc. (BHI), led by Founder, President,…
Read More
VCU-born startup Evizia lands $2.2M NIH grant for commercialization of advanced DNA sequencing microscope
As DNA research enters a critical stage in next-generation sequencing, better methods are needed to visualize and study molecules. Evizia, a company founded and…
Read More
Decentralizing Discovery: Lara Mangravite and the Mission of Digitalis Commons on BioTalk
In this episode of BioTalk, Lara Mangravite, PhD, Executive Director of Digitalis Commons, joins the conversation to explore how scientific research is shifting in…
Read More
Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference
BOSTON, MA – This week, Maryland Lt. Governor Aruna K. Miller led a Maryland delegation to the BIO International Convention in Boston, Massachusetts where she and members of the…
Read More
Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference
BOSTON, MA – This week, Maryland Lt. Governor Aruna K. Miller led a Maryland delegation to the BIO International Convention in Boston, Massachusetts where she and members of the…
Read More
Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling
BALTIMORE--(BUSINESS WIRE)--Infinity Bio, a biotechnology company pioneering technologies to map immune responses at scale, today announced the successful closing of an $8 million Series…
Read More